'We Are Not Waiting To Be Replaced': Medical Affairs Pros Take On GPT-4o

Faster, more powerful and able to handle voices and visual images, newly released AI platform GPT-4o could potentially accelerate many tasks currently handled by pharma firms' medical affairs professionals, who are exploring ways to keep themselves relevant while embracing the unprecedented technology, DIA China hears.

Generative AI ChatGPT
Medical affairs pros are already taking on GPT-4o, speakers at DIA China say • Source: Shutterstock

Boehringer Ingelheim GmbH is one of many pharma companies experimenting with new ways to leverage artificial intelligence (AI) to innovate their ways of distributing information and communicating with patients.

Key Takeaways:

  • Powerful new AI tool GPT-4o is stirring up fears that it could replace medical affairs and writing professionals.

A frontrunner among such firms looking to adopt AI, augmented reality and new digital media tools, it has already identified...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from AI

More from Advanced Technologies